MHPAEA NQTL Comparative Analysis – Delays to 2024 Rules

2025-05-28T18:28:09+00:00

The 2024 final rules under the Mental Health Parity and Addiction Equity Act (MHPAEA), issued by the U.S. Departments of Labor, Health and Human Services, and the Treasury, introduced significant changes to mental health and substance use disorder (MH/SUD) benefits. While these rules generally apply to group health plans for plan years beginning on or [...]

MHPAEA NQTL Comparative Analysis – Delays to 2024 Rules2025-05-28T18:28:09+00:00

RxDC Reporting for 2024

2025-02-05T15:25:17+00:00

The Consolidated Appropriations Act (CAA) requires that Group Health Plans report various information about their prescription drug costs and spending. The government calls the data submission of information on prescription drugs and spending the “”RxDC Report”. The government will use the data to provide insight into increased spending on prescription drugs with reporting on rebates, [...]

RxDC Reporting for 20242025-02-05T15:25:17+00:00

HIPAA Special Enrollment Rights

2024-07-24T16:18:07+00:00

HIPAA Special Enrollment Events are a subset of the Section 125 Election Change Events that provide special enrollment rights. But, unlike Section 125, HIPAA’s events are only about enrolling in your group health plan, not dis-enrolling. HIPAA requires group health plans to provide special enrollment opportunities outside the plan's regular enrollment periods in certain [...]

HIPAA Special Enrollment Rights2024-07-24T16:18:07+00:00

Annual RXDC Reporting

2023-02-08T17:45:42+00:00

The Consolidated Appropriations Act (CAA) requires that Group Health Plans report various information about their prescription drug costs and spending. The government calls the data submission of information on prescription drug costs and spending the “RxDC report.” The government will use the data to provide insight into increased spending on prescription drugs with reporting on rebates, [...]

Annual RXDC Reporting2023-02-08T17:45:42+00:00
Go to Top